The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Scabivax Contagious pustular dermatitis (Orf) vaccine Suspension for skin scarification

Intervet Ireland LimitedVPA10996/256/001

Main Information

Trade NameScabivax Contagious pustular dermatitis (Orf) vaccine Suspension for skin scarification
Active SubstancesContagious pustular dermatitis
Dosage FormCutaneous suspension
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/256/001

Group Information

ATC CodeQI04AD01 orf virus / contagious pustular dermatitis
Therapeutic ClassImmunological - Live Vaccine


License statusAuthorised
Licence Issued06/02/2004
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back